MercoPress, en Español
Montevideo, December 25th 2025 - 03:39 UTC
A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said.
Get our news on your inbox! Suscribe